Susquehanna International Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $470M | Sell |
607,800
-2,700
| -0.4% | -$2.07M | 0.05% | 278 |
|
|
2025
Q4 | $471M | Sell |
610,500
-47,800
| -7% | -$32.5M | 0.05% | 273 |
|
|
2025
Q3 | $370M | Sell |
658,300
-62,000
| -9% | -$35.1M | 0.04% | 341 |
|
|
2025
Q2 | $378M | Buy |
720,300
+193,300
| +37% | +$108M | 0.05% | 274 |
|
|
2025
Q1 | $334M | Buy |
527,000
+133,500
| +34% | +$91.8M | 0.06% | 270 |
|
|
2024
Q4 | $280M | Sell |
393,500
-106,600
| -21% | -$89.5M | 0.04% | 329 |
|
|
2024
Q3 | $526M | Buy |
500,100
+164,000
| +49% | +$183M | 0.09% | 180 |
|
|
2024
Q2 | $353M | Sell |
336,100
-47,600
| -12% | -$46.1M | 0.07% | 219 |
|
|
2024
Q1 | $369M | Sell |
383,700
-191,300
| -33% | -$182M | 0.06% | 241 |
|
|
2023
Q4 | $505M | Sell |
575,000
-5,300
| -0.9% | -$4.36M | 0.1% | 166 |
|
|
2023
Q3 | $478M | Sell |
580,300
-246,900
| -30% | -$194M | 0.1% | 140 |
|
|
2023
Q2 | $594M | Sell |
827,200
-193,100
| -19% | -$149M | 0.12% | 107 |
|
|
2023
Q1 | $838M | Buy |
1,020,300
+377,900
| +59% | +$285M | 0.18% | 75 |
|
|
2022
Q4 | $463M | Sell |
642,400
-43,500
| -6% | -$32.1M | 0.12% | 138 |
|
|
2022
Q3 | $472M | Buy |
685,900
+241,500
| +54% | +$152M | 0.12% | 124 |
|
|
2022
Q2 | $263M | Buy |
444,400
+10,600
| +2% | +$6.89M | 0.07% | 237 |
|
|
2022
Q1 | $303M | Sell |
433,800
-283,900
| -40% | -$180M | 0.05% | 286 |
|
|
2021
Q4 | $453M | Sell |
717,700
-225,200
| -24% | -$138M | 0.07% | 229 |
|
|
2021
Q3 | $571M | Sell |
942,900
-159,900
| -14% | -$99.3M | 0.08% | 201 |
|
|
2021
Q2 | $616M | Sell |
1,102,800
-194,000
| -15% | -$98.3M | 0.09% | 186 |
|
|
2021
Q1 | $614M | Buy |
1,296,800
+48,600
| +4% | +$23.7M | 0.1% | 159 |
|
|
2020
Q4 | $603M | Buy |
1,248,200
+521,000
| +72% | +$281M | 0.1% | 147 |
|
|
2020
Q3 | $407M | Buy |
727,200
+21,400
| +3% | +$13M | 0.08% | 184 |
|
|
2020
Q2 | $440M | Sell |
705,800
-20,800
| -3% | -$11.8M | 0.11% | 150 |
|
|
2020
Q1 | $355M | Buy |
726,600
+35,300
| +5% | +$14.6M | 0.11% | 144 |
|
|
2019
Q4 | $260M | Buy |
691,300
+84,200
| +14% | +$28.3M | 0.07% | 216 |
|
|
2019
Q3 | $168M | Buy |
607,100
+124,200
| +26% | +$36.8M | 0.06% | 280 |
|
|
2019
Q2 | $151M | Sell |
482,900
-78,700
| -14% | -$26.2M | 0.05% | 294 |
|
|
2019
Q1 | $231M | Sell |
561,600
-300,100
| -35% | -$124M | 0.09% | 171 |
|
|
2018
Q4 | $322M | Buy |
861,700
+35,400
| +4% | +$13M | 0.13% | 128 |
|
|
2018
Q3 | $334M | Buy |
826,300
+112,200
| +16% | +$42.7M | 0.11% | 140 |
|
|
2018
Q2 | $246M | Buy |
714,100
+53,700
| +8% | +$16.8M | 0.08% | 196 |
|
|
2018
Q1 | $227M | Sell |
660,400
-486,400
| -42% | -$169M | 0.08% | 195 |
|
|
2017
Q4 | $431M | Sell |
1,146,800
-65,600
| -5% | -$26.6M | 0.15% | 96 |
|
|
2017
Q3 | $542M | Buy |
1,212,400
+59,200
| +5% | +$28.2M | 0.21% | 66 |
|
|
2017
Q2 | $566M | Buy |
1,153,200
+346,900
| +43% | +$152M | 0.25% | 54 |
|
|
2017
Q1 | $312M | Buy |
806,300
+189,600
| +31% | +$70.3M | 0.16% | 102 |
|
|
2016
Q4 | $226M | Sell |
616,700
-23,000
| -4% | -$8.75M | 0.11% | 147 |
|
|
2016
Q3 | $257M | Sell |
639,700
-132,400
| -17% | -$53.1M | 0.12% | 126 |
|
|
2016
Q2 | $270M | Buy |
772,100
+144,100
| +23% | +$55.5M | 0.14% | 113 |
|
|
2016
Q1 | $226M | Sell |
628,000
-276,000
| -31% | -$114M | 0.12% | 126 |
|
|
2015
Q4 | $491M | Buy |
904,000
+130,700
| +17% | +$70.8M | 0.23% | 64 |
|
|
2015
Q3 | $360M | Sell |
773,300
-35,700
| -4% | -$19.2M | 0.16% | 103 |
|
|
2015
Q2 | $413M | Buy |
809,000
+15,300
| +2% | +$7.47M | 0.18% | 77 |
|
|
2015
Q1 | $358M | Sell |
793,700
-48,900
| -6% | -$20.7M | 0.16% | 92 |
|
|
2014
Q4 | $346M | Buy |
842,600
+207,800
| +33% | +$81.7M | 0.14% | 130 |
|
|
2014
Q3 | $229M | Sell |
634,800
-58,600
| -8% | -$19.6M | 0.09% | 186 |
|
|
2014
Q2 | $196M | Sell |
693,400
-73,900
| -10% | -$21.9M | 0.08% | 192 |
|
|
2014
Q1 | $230M | Buy |
767,300
+165,300
| +27% | +$50.9M | 0.11% | 151 |
|
|
2013
Q4 | $166M | Buy |
602,000
+226,800
| +60% | +$65.2M | 0.08% | 208 |
|
|
2013
Q3 | $117M | Buy |
375,200
+7,600
| +2% | +$2M | 0.06% | 263 |
|
|
2013
Q2 | $82.7M | Buy |
+367,600
| New | +$85.6M | 0.05% | 328 |
|
Other funds holding REGN
VCM
N
Susquehanna International Group's REGN Position: Q1 2026 in Review
Susquehanna International Group reduced its Regeneron Pharmaceuticals (REGN) stake by 67% in Q1 2026, selling an estimated $47.3M and leaving 30,620 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.
Susquehanna International Group first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $344M in Q4 2020. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Susquehanna International Group held 30,620 shares of Regeneron Pharmaceuticals worth $23.7M as of Q1 2026.
- Susquehanna International Group sold 61,841 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $47.3M.
- Regeneron Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2017 holding.
- Susquehanna International Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Susquehanna International Group's Regeneron Pharmaceuticals position peaked at $344M in Q4 2020.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.